Turning Point Benefit Group’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-115
Closed -$284 100
2025
Q4
$284 Hold
115
﹤0.01% 722
2025
Q3
$254 Buy
+115
New +$263 ﹤0.01% 618

Other funds holding ABEV

Turning Point Benefit Group's ABEV Position: Q1 2026 in Review

Turning Point Benefit Group sold out of Ambev (ABEV) in Q1 2026, closing a stake of 115 shares — an estimated $284 sold.

Turning Point Benefit Group first reported a position in ABEV in Q3 2025 and held it in 2 quarters. The position peaked at $284 in Q4 2025. 403 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

  • Turning Point Benefit Group reported no remaining Ambev position as of Q1 2026 after selling out during the quarter.
  • Turning Point Benefit Group sold 115 Ambev shares in Q1 2026, an estimated $284.
  • Turning Point Benefit Group first reported a position in Ambev in Q3 2025 and held it in 2 quarters.
  • Turning Point Benefit Group's Ambev position peaked at $284 in Q4 2025.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.